Page last updated: 2024-10-27

berotek and MS (Multiple Sclerosis)

berotek has been researched along with MS (Multiple Sclerosis) in 2 studies

Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.

Research Excerpts

ExcerptRelevanceReference
" The dose-response relationship was similar within the non-asthma patients."1.40Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study. ( Lee, CT; Lin, FC; Tsai, CP, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yong, HY1
McKay, KA1
Daley, CGJ1
Tremlett, H1
Tsai, CP1
Lin, FC1
Lee, CT1

Reviews

1 review available for berotek and MS (Multiple Sclerosis)

ArticleYear
Drug exposure and the risk of multiple sclerosis: A systematic review.
    Pharmacoepidemiology and drug safety, 2018, Volume: 27, Issue:2

    Topics: Adrenergic beta-2 Receptor Agonists; Antirheumatic Agents; Fenoterol; Histamine H1 Antagonists; Huma

2018

Other Studies

1 other study available for berotek and MS (Multiple Sclerosis)

ArticleYear
Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2014, Volume: 20, Issue:12

    Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Case-Control Studies; Child; Chil

2014